2025 International Congress Archives - Page 35 of 181

Characterization of the Dnajc13 p.N860S mouse model, a physiological model of alpha-Synuclein overexpression

J. Follett, J. Fox, I. Deng, S. Wall, A. Rajput, A. Rajput, M. Farrer (Gainesville, USA)
Characterizing the Neural Signature of Parkinsonian Freezing of Gait During an Immersive Virtual Reality Paradigm

M. Miller Koop, A. Rosenfeldt, K. Scelina, L. Scelina, C. Waltz, A. Bazyk, V. Berki, K. Baker, N. Malan, S. Nagel, B. Walter, J. Liao, K. Baker, J. Alberts (Cleveland, USA)
Characterizing the Patient Clinical Journey Before and After Diagnosis of Friedreich Ataxia and Differences by Age at Diagnosis

A. Henriquez, M. Hatcher, B. Bian, A. Didonato, S. England, Q. Ip, X. Ma, J. Mckay, R. Avila (Seattle, USA)
Cholinergic activity associates with cognitive function in PD using [18F]VAT

J. O'Donnell, A. Eid, H. Hwang, S. Grossen, J. Hood, E. Foster, Z. Tu, J. Perlmutter, M. Campbell (St. Louis, USA)
Chorea as the initial presentation of Erdheim-Chester disease

I. Sarac, H. Sarac, S. Basic Kinda, F. Borovecki, N. Henigsberg, L. Lugovi Mihic (Zagreb, Croatia)
Chorea-acanthocytosis in Puerto Rico: A Case Series

E. Pérez-Luciano, C. Chapel-Crespo, D. Lozada-Figueroa, I. Pita-García, L. Surillo-Dahdah (Ponce, Puerto Rico)
Chorea,dystonia, and tics:lessons learned from the clinical pattern associated with VPS13A disease

H. Saglam, J. Frey (Morgantown, USA)
Chronic DBS Stimulation’s effects after 1-hour off stimulation

M. Varga, Y. Zhao, S. Santacruz (Austin, USA)
Chronic Exercise and Systemic Inflammation in Parkinson’s Disease: Exploring the Role of Exercise Modality

J. Cristini, F. Seo, A. Bon, A. Potvin-Desrochers, J. Mustafa, A. Dagher, R. Postuma, P. Rosa-Neto, J. Carrier, A. Amara, S. Steib, C. Paquette, M. Roig (Montreal, Canada)
Chronic kidney disease, proteinuria, and mortality risk in patients with Parkinson’s disease: A longitudinal study

K. Baik, M. Park, M. Kang, YJ. Park, SJ. Chung, K. Oh, SH. Kang, S. Koh (Seoul, Republic of Korea)